A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease

Only a minority of prostate cancers lead to death. Because no tissue biomarkers of aggressiveness other than Gleason score are available at diagnosis, many nonlethal cancers are treated aggressively. We evaluated whether a panel of biomarkers, associated with a range of disease outcomes in previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Severi, Gianluca, FitzGerald, Liesel M, Muller, David C, Pedersen, John, Longano, Anthony, Southey, Melissa C, Hopper, John L, English, Dallas R, Giles, Graham G, Mills, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302676/
https://www.ncbi.nlm.nih.gov/pubmed/24909936
http://dx.doi.org/10.1002/cam4.281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302676/
https://www.ncbi.nlm.nih.gov/pubmed/24909936
http://dx.doi.org/10.1002/cam4.281

Ejemplares similares